Herbal medicines for the management of irritable bowel syndrome: A comprehensive review

World Journal of Gastroenterology

Volumn 18, Issue 7, 2012, Pages 589-600

  Rahimi, Roja ^a   Abdollahi, Mohammad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Herbal medicines; Irritable bowel syndrome; Systematic review

Indexed keywords

AGRIMONIA EUPATORIA EXTRACT; ALOE VERA EXTRACT; AVENA SATIVA EXTRACT; CARMINT; CINNAMOMUM ZEYLANICUM EXTRACT; CODONOPSIS PILOSULAE EXTRACT; CURCUMA LONGA EXTRACT; CURCUMA XANTHORRIZA EXTRACT; CYNARA SCOLYMUS EXTRACT; FUMARIA OFFICINALIS EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IBERIS AMARA EXTRACT; IBEROGAST; ISPAGULA; LACTULOSE; LEDEBOURIELLA SESLOIDIS EXTRACT; LOPERAMIDE; MARANTA ARUNDINACEA EXTRACT; MENTHE PIPERITA EXTRACT; PADMA LAX; PAEONIA LACTIFLORA EXTRACT; PEPPERMINT OIL; PLANTAGO PSYLLIUM EXTRACT; TONG XIE NING; TONG XIE YAO FANG; ULMUS FULVA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINIUM MYRTILLUS EXTRACT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; AGRIMONIA EUPATORIA; ANALGESIC ACTIVITY; ANTIMICROBIAL ACTIVITY; AUTONOMIC NERVOUS SYSTEM; BACTERICIDAL ACTIVITY; BINDING AFFINITY; BLOATING; CHINESE HERB; CHINESE MEDICINE; CINNAMOMUM ZEYLANICUM; CODONOPSIS PILOSULAE; CONSTIPATION; CURCUMA; CURCUMA XANTHORRIZA; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DYSPEPSIA; EDITORIAL; FLATULENCE; FUMARIA OFFICINALIS; GASTROINTESTINAL SYMPTOM; HEARTBURN; HERBAL MEDICINE; HUMAN; IBERIS AMARA; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; IRRITABLE COLON; LEDEBOURIELLA SESLOIDIS; LOOSE FECES; MARANTA ARUNDINACEA; MEDICINAL PLANT; MENTAL STRESS; MENTHE PIPERITA; NONHUMAN; OAT; PLANT LEAF; PLANT ROOT; PLANTAGO PSYLLIUM; QUALITY OF LIFE; RHIZOME; SINGLE DRUG DOSE; SPASMOLYSIS; STOMACH MOTILITY; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE; TREATMENT DURATION; ULMUS FULVA;

EID: 84857410412     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i7.589     Document Type: Editorial

References (71)

1. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci 2010; 31: 326-334
2. Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010; 25: 691-699
3. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009; 24: 1601-1607
4. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20 Suppl 2: 1-9
5. Karantanos T, Markoutsaki T, Gazouli M, Anagnou NP, Karamanolis DG. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog 2010; 2: 3
6. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a metaanalysis. World J Gastroenterol 2009; 15: 1548-1553
7. Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials. Arch Med Sci 2008; 4: 71-76
8. Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010; 16: 547-553
9. Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337: a2313
10. Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Clin Ther 2008; 30: 884-901
11. Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009; 104: 1831-1843; quiz 1844
12. Rezaie A, Nikfar S, Abdollahi M. The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis. Arch Med Sci 2010; 6: 49-55
13. Nikfar S, Rahimi R, Rahimi F, Derakhshani S, Abdollahi M. Efficacy of probiotics in irritable bowel syndrome: a metaanalysis of randomized, controlled trials. Dis Colon Rectum 2008; 51: 1775-1780
14. Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des 2010; 16: 3646-3655
15. Duracinsky M, Chassany O. [How can an effective drug to treat irritable bowel syndrome be successfully developed?]. Gastroenterol Clin Biol 2009; 33 Suppl 1: S26-S34
16. Wu JC. Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths? Gastroenterol Hepatol (NY) 2010; 6: 705-711
17. Davis K, Philpott S, Kumar D, Mendall M. Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome. Int J Clin Pract 2006; 60: 1080-1086
18. Bundy R, Walker AF, Middleton RW, Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med 2004; 10: 1015-1018
19. Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stützer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol 2005; 40: 936-943
20. Zaidi SF, Yamada K, Kadowaki M, Usmanghani K, Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J Ethnopharmacol 2009; 121: 286-291
21. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57: 1-7
22. Gilani AH, Shah AJ, Ghayur MN, Majeed K. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 2005; 76: 3089-3105
23. Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis. J Altern Complement Med 2004; 10: 667-669
24. Walker AF, Middleton RW, Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study. Phytother Res 2001; 15: 58-61
25. Costabile A, Kolida S, Klinder A, Gietl E, Bäuerlein M, Frohberg C, Landschütze V, Gibson GR. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br JNutr 2010; 104: 1007-1017
26. Emendörfer F, Emendörfer F, Bellato F, Noldin VF, Cechinel-Filho V, Yunes RA, Delle Monache F, Cardozo AM. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum. Biol Pharm Bull 2005; 28: 902-904
27. Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 118-127
28. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A randomized, doubleblind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol 2010; 105: 170-177
29. Wan H, Chen Y. Effects of antidepressive treatment of Saint John's wort extract related to autonomic nervous function in women with irritable bowel syndrome. Int J Psychiatry Med 2010; 40: 45-56
30. Cooke C, Carr I, Abrams K, Mayberry J. Arrowroot as a treatment for diarrhoea in irritable bowel syndrome patients: a pilot study. Arq Gastroenterol 2000; 37: 20-24
31. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol 1998; 93: 1131-1135
32. Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Entericcoated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997; 32: 765-768
33. Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci 2010; 55: 1385-1390
34. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis 2007; 39: 530-536
35. Kline RM, Kline JJ, Di Palma J GJ. Enteric-coated, pHdependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001; 138: 125-128
36. Logan AC, Beaulne TM. The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report. Altern Med Rev 2002; 7: 410-417
37. Grigoleit HG, Grigoleit P. Pharmacology and preclinical pharmacokinetics of peppermint oil. Phytomedicine 2005; 12: 612-616
38. Hiki N. [Peppermint oil reduces gastric motility during the upper gastrointestinal endoscopy]. Nihon Rinsho 2010; 68: 2126-2134
39. Zhang XJ, Li Z, Leung WM, Liu L, Xu HX, Bian ZX. The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats. J Pain 2008; 9: 497-505
40. Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009; 339: b3154
41. Vejdani R, Shalmani HR, Mir-Fattahi M, Sajed-Nia F, Abdollahi M, Zali MR, Mohammad Alizadeh AH, Bahari A, Amin G. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study. Dig Dis Sci 2006; 51: 1501-1507
42. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998; 280: 1585-1589
43. Sallon S, Ben-Arye E, Davidson R, Shapiro H, Ginsberg G, Ligumsky M. A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula. Digestion 2002; 65: 161-171
44. Madisch A, Holtmann G, Plein K, Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19: 271-279
45. Krueger D, Gruber L, Buhner S, Zeller F, Langer R, Seidl S, Michel K, Schemann M. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine. Neurogastroenterol Motil 2009; 21: 1203-e110
46. Simmen U, Kelber O, Okpanyi SN, Jaeggi R, Bueter B, Weiser D. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors. Phytomedicine 2006; 13 Suppl 5: 51-55
47. Müller MH, Liu CY, Glatzle J, Weiser D, Kelber O, Enck P, Grundy D, Kreis ME. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Phytomedicine 2006; 13 Suppl 5: 100-106
48. Ammon HP, Kelber O, Okpanyi SN. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomedicine 2006; 13 Suppl 5: 67-74
49. Schemann M, Michel K, Zeller F, Hohenester B, Rühl A. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine 2006; 13 Suppl 5: 90-99
50. Michael S, Kelber O, Hauschildt S, Spanel-Borowski K, Nieber K. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. Phytomedicine 2009; 16: 161-171
51. Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebocontrolled trial. Am J Gastroenterol 2006; 101: 1574-1580
52. Wang G, Li TQ, Wang L, Xia Q, Chang J, Zhang Y, Wan MH, Guo J, Cheng Y, Huang X, Zhang RM. Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Zhanghua Yixue Zazhi 2006; 119: 2114-2119
53. Pan F, Zhang T, Zhang YH, Xu JJ, Chen FM. Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome. Chin J Integr Med 2009; 15: 216-219
54. Hu X, Xu D, Zhao Y, Yang X, Meng J, Shen H, Guo J. The Alleviating Pain Effect of Aqueous Extract from Tong-Xie-Yao-Fang, on Experimental Visceral Hypersensitivity and Its Mechanism. Biol Pharm Bull 2009; 32: 1075-1079
55. Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med 2010; 16: 1065-1071
56. Rahimi R, Shams-Ardekani MR, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol 2010; 16: 4504-4514
57. Tonkaboni A, Resaleh Eshalieh, Rezayizadeh H, Rostambakhsh MR, Tafaghod R, Yazdani M, editors. Tehran: Almaee, 2009: 109-119 Available from: URL: http: //www.adinebook.com/gp/product/9647553315
58. Tonkaboni MM, Tohfeh al-Momenin, Rahimi R, Shams Ardekani MR, Farjadmand F, editors. Tehran: Shahid Beheshti University of Medical Sciences, 2007. Available from: URL: http: //www.adinebook.com/gp/product/9642657971
59. Aghili MH, Makhzan-al-Advia, Rahimi R, Shams Ardekani MR, Farjadmand F, editors. Tehran: Tehran University of Medical Sciences, 2009. Available from: URL: http: //aqlibrary. org/UserFiles/File/makhzan.pdf
60. Fan AY, Lao L, Zhang RX, Wang LB, Lee DY, Ma ZZ, Zhang WY, Berman B. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation. J Altern Complement Med 2005; 11: 323-331
61. Banno N, Akihisa T, Yasukawa K, Tokuda H, Tabata K, Nakamura Y, Nishimura R, Kimura Y, Suzuki T. Antiinflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol 2006; 107: 249-253
62. Badria FA, Mikhaeil BR, Maatooq GT, Amer MM. Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Z Naturforsch C 2003; 58: 505-516
63. Hawrelak JA, Cattley T, Myers SP. Essential oils in the treatment of intestinal dysbiosis: A preliminary in vitro study. Altern Med Rev 2009; 14: 380-384
64. Magalhães CB, Riva DR, DePaula LJ, Brando-Lima A, Koatz VL, Leal-Cardoso JH, Zin WA, Faffe DS. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol 2010; 108: 845-851
65. Carrasco FR, Schmidt G, Romero AL, Sartoretto JL, Caparroz-Assef SM, Bersani-Amado CA, Cuman RK. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor-and cell-mediated responses. J Pharm Pharmacol 2009; 61: 961-967
66. Friedman M, Henika PR, Mandrell RE. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J Food Prot 2002; 65: 1545-1560
67. Kaur G, Hamid H, Ali A, Alam MS, Athar M. Antiinflammatory evaluation of alcoholic extract of galls of Quercus infectoria. J Ethnopharmacol 2004; 90: 285-292
68. Vermani A. Screening of Quercus infectoria gall extracts as anti-bacterial agents against dental pathogens. Indian J Dent Res 2009; 20: 337-339
69. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305
70. Wanner J, Bail S, Jirovetz L, Buchbauer G, Schmidt E, Gochev V, Girova T, Atanasova T, Stoyanova A. Chemical composition and antimicrobial activity of cumin oil (Cuminum cyminum, Apiaceae). Nat Prod Commun 2010; 5: 1355-1358
71. Badr SE, Shaaban M, Elkholy YM, Helal MH, Hamza AS, Masoud MS, El Safty MM. Chemical composition and biological activity of ripe pumpkin fruits (Cucurbita pepo L.) cultivated in Egyptian habitats. Nat Prod Res 2011; 25: 1524-1539